Small Business Awards 2017

4 CORPORATE VISION / 2017 Small Business Awards , Drawing on over 96 years’ experience, Sintetica SA is an innovative pharmaceutical firmbased in Switzerland. We invited CEOAugusto Mitidieri to tell us more about the firmand the secrets behind its success. Respect as core value Established 1921 in Switzerland, Sintetica is a pharmaceutical company delivering injectable anaesthetics and analgesics to patients worldwide, through innovative science and excellence in development, production and marketing. Augusto talks us through the firm’s service offering in more detail and explains how, working in such a vital industry, it works to ensure excellence at all times. “Local anaesthesia and pain relief are two areas in which we at Sintetica have been the market leader for many years in Switzerland. Moreover, we are also seeking to develop a leadership position in the growing field of neuromodulation. Beginning in 2012, we established the global division, which was the first international corporate structure. The global division was tasked with pursuing international growth under two distinct models, being a B2B licensing strategy and somewhat later a B2C strategy in select markets. “Under the B2B model, we sought to license out our top brands to partners with whom we shared values. Foremost among these values is that people and relationships, including business relationships, come first, and thus Sintetica seeks to build business by finding partners with whom we can share our values. As such, all our partners must meet strict ethical criteria and share our innovation driven ‘quality without compromise’ value proposition. This was the most critical and difficult challenge we have faced since beginning our internationalization efforts, however I am proud to say that we have been very successful “Today, we have submitted more than 300 product registrations in over 100 different countries via the network of partners we have built over the last five years. The first phase of expansion covered North, Central and South America, South East Asia, and the Pacific. Many of these registrations have yet to come through, but so far, we have seen strong growth in the US, and some good returns in the Pacific. YOY Global Division growth is largely exceeding 70%, consolidating the impressive growth stream of the last years.” Leading such a dynamic vital organisation is a challenging and exciting venture, therefore Augusto is dedicated to lead by example, and imbibes his passion and drive into every aspect of the business, as he highlights. “Here at Sintetica, we are fully committed to innovate therapies and drugs in local anaesthesia, pain management and neuromodulation. As such, we move forward with passion and competence in the full respect of people and the environment. All our efforts and resources are focused to become leader in these fields by developing novel medicine and better treatment options for physicians and patients worldwide. “To achieve this leadership by innovation in the context of global growth, we consider strategic partnering and business development the key factors. Therefore, our Global division is focusing on high speed robust partner selection and affiliation in every country of the world. It is determined to offer a dynamic portfolio of selected branded medicines, developed to answer unmet clinical needs, to build sustainable and long-lasting alliances.” To ensure true excellence at all times, Augusto implements a people centric internal culture which he is eager to discuss. SB170005